Moderna Expands Its mRNA Pipeline With Three New Development Programs
mRNA-1608 is a vaccine candidate against Herpes simplex virus (HSV)
mRNA-1468 is a vaccine candidate against varicella-zoster virus (VZV) to reduce the rate of herpes zoster (shingles)
mRNA-4359 is a new checkpoint cancer vaccine...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Cancer Vaccines | Clinical Trials | Cold Sores | Herpes | Pharmaceuticals | Shingles | Shingles (Herpes Zoster) Vaccine | Vaccines | Varicella-Zoster Virus Vaccine